Cellyan Biotechnology Co., Ltd (HKPD)

HK — Healthcare Sector
Peers: LSH  PSIG  CRGO  UUU  NCEW  JYD  TLIH  VRME  ARTW  ATXG 

Automate Your Wheel Strategy on HKPD

With Tiblio's Option Bot, you can configure your own wheel strategy including HKPD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HKPD
  • Rev/Share 1.9626
  • Book/Share 0.4821
  • PB 1.5972
  • Debt/Equity 0.4759
  • CurrentRatio 2.9915
  • ROIC -0.1

 

  • MktCap 8470000.0
  • FreeCF/Share 0.0482
  • PFCF 16.9637
  • PE -294.5707
  • Debt/Assets 0.2522
  • DivYield 0
  • ROE -0.0052

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 3
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Cellyan Biotechnology Co., Ltd (HKPD)

  • IPO Date 2025-01-15
  • Website http://www.9zt.hk
  • Industry Medical - Pharmaceuticals
  • CEO Chenyu Liang
  • Employees 27
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.